BCR-ABL Tyrosine Kinase Inhibitors: Which Mechanism(s) May Explain the Risk of Thrombosis?

Hélène Haguet; Jonathan Douxfils; Christian Chatelain; Carlos Graux; François Mullier; Jean-Michel Dogné

doi:10.1055/s-0038-1624566

BCR-ABL Tyrosine Kinase Inhibitors: Which Mechanism(s) May Explain the Risk of Thrombosis?

Hélène Haguet, Jonathan Douxfils, Christian Chatelain, Carlos Graux, François Mullier, Jean-Michel Dogné

Research output: Contribution to journal › Review article › peer-review

51 Downloads (Pure)

Original language	English
Pages (from-to)	e68-e88
Journal	TH Open
Volume	02
Issue number	1
DOIs	https://doi.org/10.1055/s-0038-1624566
Publication status	Published - 2018

Keywords

BCR-ABL
arterial thrombotic events
tyrosine kinase inhibators
chronic myeloid leukemia

Access to Document

10.1055/s-0038-1624566

THO_170017

The DIT project : Drug induced thrombosis - a special focus on kinase and PARP inhibitors and
Douxfils, J. (Supervisor), Mullier, F. (Co-supervisor), Haguet, H. (Researcher) & RONVAUX, L. (Researcher)
1/09/15 → …
Project: Research

Cite this

@article{66a27f13c8b24ae3ad3cff556782919b,

title = "BCR-ABL Tyrosine Kinase Inhibitors: Which Mechanism(s) May Explain the Risk of Thrombosis?",

keywords = "BCR-ABL, arterial thrombotic events, tyrosine kinase inhibators, chronic myeloid leukemia",

author = "H{\'e}l{\`e}ne Haguet and Jonathan Douxfils and Christian Chatelain and Carlos Graux and Fran{\c c}ois Mullier and Jean-Michel Dogn{\'e}",

year = "2018",

doi = "10.1055/s-0038-1624566",

language = "English",

volume = "02",

pages = "e68--e88",

journal = "TH Open",

issn = "2512-9465",

publisher = "Thieme Medical Publishers",

number = "1",

}

TY - JOUR

T1 - BCR-ABL Tyrosine Kinase Inhibitors

T2 - Which Mechanism(s) May Explain the Risk of Thrombosis?

AU - Haguet, Hélène

AU - Douxfils, Jonathan

AU - Chatelain, Christian

AU - Graux, Carlos

AU - Mullier, François

AU - Dogné, Jean-Michel

PY - 2018

Y1 - 2018

KW - BCR-ABL

KW - arterial thrombotic events

KW - tyrosine kinase inhibators

KW - chronic myeloid leukemia

U2 - 10.1055/s-0038-1624566

DO - 10.1055/s-0038-1624566

M3 - Review article

SN - 2512-9465

VL - 02

SP - e68-e88

JO - TH Open

JF - TH Open

IS - 1

ER -

BCR-ABL Tyrosine Kinase Inhibitors: Which Mechanism(s) May Explain the Risk of Thrombosis?

Keywords

Access to Document

Projects

The DIT project : Drug induced thrombosis - a special focus on kinase and PARP inhibitors and

Cite this